Featured article

Leveraging AI in early stage drug discovery and due diligence: Autobahn Labs & Causaly webinar

"Switching over to Causaly has been transformative" Dr. Yuxi Lin, Associate Director of Project Management at Autobahn Labs Causaly and...
Causaly raises $17 million to accelerate biomedical research and discovery of scientific breakthroughs
News

Causaly raises $17 million to accelerate biomedical research and discovery of scientific breakthroughs

Causaly, the London-based company that allows researchers and specialists to intuitively map and navigate the intricate landscape of biomedical research, has raised $17 million from investors to grow its team and expand into new markets.

The Causaly Machine-Reading Platform: From finding documents to finding evidence - ODSC

The Causaly Machine-Reading Platform: From finding documents to finding evidence - ODSC

Causaly ODSC Seminar Causaly's CTO, Artur Saudabayev, hosted an ODSC seminar on the 30th of March addressing the problem of the rapidly...

Causaly vs PubMed®: 2x as many relevant articles identified by Causaly using the same data
use case

Causaly vs PubMed®: 2x as many relevant articles identified by Causaly using the same data

Causaly AI finds more relevant articles than PubMed alone, using its advanced machine-reading technology.

Target identification and validation using AI for literature-based insights: Causaly & Pierre Fabre Joint Webinar

Target identification and validation using AI for literature-based insights: Causaly & Pierre Fabre Joint Webinar

Causaly and Pierre Fabre joint webinar Causaly and Pierre Fabre co-hosted a joint webinar on the 28th of October, addressing how...

Sign up for Causaly newsletter